Parkman Healthcare Partners’s Curis CRIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-490
Closed -$2.22M 87
2021
Q1
$2.22M Buy
490
+2
+0.4% +$8.36K 0.52% 53
2020
Q4
$1.6M Buy
+488
New +$586K 0.41% 64

Other funds holding CRIS

Parkman Healthcare Partners's CRIS Position: Q2 2021 in Review

Parkman Healthcare Partners sold out of Curis (CRIS) in Q2 2021, closing a stake of 490 shares — an estimated $2.22M sold.

Parkman Healthcare Partners first reported a position in CRIS in Q4 2020 and held it in 2 quarters. The position peaked at $2.22M in Q1 2021. 127 funds tracked by Wall St. Rank hold CRIS as of Q2 2021.

  • Parkman Healthcare Partners reported no remaining Curis position as of Q2 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 490 Curis shares in Q2 2021, an estimated $2.22M.
  • Parkman Healthcare Partners first reported a position in Curis in Q4 2020 and held it in 2 quarters.
  • Parkman Healthcare Partners's Curis position peaked at $2.22M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Curis as of Q2 2021.

Based on Parkman Healthcare Partners's 13F filing for Q2 2021, filed 13 Aug 2021.